Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today! CAMBRIDGE, Mass.-- --Verastem, Inc., focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced the initiation of a Phase 1 trial of VS-4718, a novel, small molecule inhibitor of focal adhesion ... (more)
http://www.biospace.com/news_story.aspx?StoryID=301216&full=1
http://www.biospace.com/news_story.aspx?StoryID=301216&full=1
No comments:
Post a Comment